India coronavirus main medical research organization has asked states to pause the use of rapid testing kits over concerns that they are faulty.
Several states have complained that the kits – which are supposed to test for the presence of antibodies against the coronavirus – are malfunctioning.
In a statement last week, China said it attached “great importance to the export of medical products”.
What is happening in India coronavirus?
At least three Indian states have expressed dissatisfaction with the kits, with the northern state of Rajasthan refusing outright to use them.
Officials there said the state only had an accuracy of 5%. They added that they used the kits on India coronavirus patients who they already knew were positive, but the tests had shown a “negative” result.
- Should people pay for their own COVID-19 tests?
- Inside India’s busiest COVID-19 hospital
- Why is India testing so little?
How are the India coronavirus tests supposed to work?
It has been likened in some cases to a simple “yes/no” pregnancy test.
The kits had been hailed as a “game-changer” tool to help restart economies across the world and governments ordered them in large amounts from China, in addition to trying to develop their own.
However, they are running into problems in a number of countries, including the US and the UK.
What issues are being faced in other countries?
In the US, the New York Times reported that tests of “frankly dubious quality” have flooded the American market, saying that it has been found that it mistakenly flags some people as having antibodies when they actually don’t.
In the UK, scientists have said that the tests have a low sensitivity rate and Health Secretary Matt Hancock told the media that they were “not good enough” as yet.